CGRP Forum
Send to a colleague
Register  Login
Home   |   About   |   About CGRP   |   News   |   Hot Topics   |   Trials    |   Resources   |   Contact

Migraine: a new treatment landscape

In the last in the current series of videos about recent developments in anti-CGRP therapy, CGRP Forum Co-Editor Peter Goadsby discusses the likely impact of CGRP monoclonal antibodies and gepants on the treatment landscape. He welcomes the growing opportunities for patients to be offered individualised treatment that enables them to take back control of their lives.

Watch the video here »


If you missed any previous videos in this series with Peter Goadsby, take a look at:

What next for anti-CGRP therapy?

There is still much to learn about how treatment for migraine prevention fits into daily practice.

Watch the video here »

CGRP therapies for acute migraine

Looking at the potential impact of targeting the CGRP pathway for both prevention and treatment of migraine.

Watch the video here »

CGRP in cluster headache

The need to optimise therapy for those most likely to benefit.

Watch the video here »



For all the other recent migraine news featured on the CGRP Forum click here »

Becoming a member is easy

Members have free open access simply by registering online.
Facebook Like us on Facebook
For the latest updates, CGRP news and analysis.
Twitter Follow us on Twitter
Hot topics, news and conference reports.
Educational Partners and Supporters (others pending) Logos
© Copyright CGRP Forum 2020. Please click here to unsubscribe from future mailings.
‚Äč